Clean data supports more accurate analysis and better decisions
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREA large pharmaceutical company used to handle their data stewardship with a mixed model of contracted staff augmentation and another vendor. However, that model caused them some concerns, including data stewardship quality, throughput (number of closed requests), and the vendors' pharma industry and data stewardship experience. In addition, the three-day service-level agreement (SLA) was only being met half of the time. The company realized that its current model was unsustainable. It needed a team with more experience in Data Governance & Stewardship (DG&S) that specialized knowledge of the pharma industry. Read the case study to learn how IQVIA was able to help reduce turnaround time, increase daily data steward throughput and reduce change requests by 33%.
Clean data supports more accurate analysis and better decisions
Unleash the power of your data across the enterprise
Leverage technology to maximize value and minimize risk
Harness the power of your data